Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Kala Pharmaceuticals Inc. logo

Kala Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

5.71
 
USD
  
-0.27
  
(-4.52%)
Optionable: Yes  Market Cap: 16 M  90-day average vol: 17,895

Previous close: 5.98  Open: 6.2  Bid: 5.64  Ask: 6.04
52 week range    
3.54   
   56.72
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Thursday 30th November 2023
35
MarketXLS Rank
40
Value
38
Technical
28
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

KALA Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends0.0
Basic EPS from continuing operations-124.5-138.0
Basic EPS total-124.5-138.00.0-2.19-29.48
Basic weighted shares outstanding138064.0535078.0684195.01 M65 M2 M
CommissionExpenses-100000.0-262000.00.0
Depreciation-287000.0-352000.0-843000.0-908000.0-933000.0-421000.0
DepreciationAndAmortization-287000.0-352000.0-843000.0-908000.0-933000.0-421000.0
Diluted EPS total-305.5-124.5-138.0-99.5-2.19-29.48
Diluted normalized net income/share-99.5
Diluted weighted shares outstanding138170.0535078.0684195.0984733.065 M2 M
Earnings from equity interest-4000.0
EarningsFromEquityInterestNetOfTax-4000.0
Fees9 M5 M8 M
GainOnSaleOfBusiness47 M
GainOnSaleOfSecurity1 M
GeneralAndAdministrativeExpense-396000.035 M65 M-7 M-6 M-1 M
Gross operating profit9 M5 M6 M8 M
Income before tax-42 M-67 M-90 M-104 M-143 M-45 M
Interest income527000.02 M2 M493000.0104000.0664000.0
InterestExpenseNonOperating1 M3 M8 M9 M8 M7 M
InterestIncomeOperating4000.0
MiscOtherSpecialCharges-2 M-390000.06 M6 M383000.0
Net income from total operations-42 M-67 M-90 M-104 M-143 M-45 M
NetIncomeCommonStockholders-42 M-67 M-90 M-104 M-143 M-45 M
NetIncomeContinuousOperations-42 M-67 M-90 M-104 M-143 M-45 M
NetNonOperatingInterestIncomeExpense-492000.0-2 M-6 M-8 M-8 M-7 M
Operating income-40 M-65 M-84 M-103 M-141 M-86 M
Operating income before depreciation (EBITDA)-41 M-63 M-80 M-94 M-132 M-36 M
OperatingExpense-40 M65 M90 M103 M-141 M-86 M
Other income net2 M390000.0-6 M-7 M-47 M
OtherGandA-396000.035 M65 M-7 M-6 M-1 M
OtherOperatingExpenses-40 M-65 M-2 M3 M-2 M3 M
RentAndLandingFees0.0
Research & development expense29 M29 M27 M18 M38 M18 M
ResearchExpense29 M29 M27 M18 M38 M18 M
SalariesAndWages-4 M-13 M-16 M-7 M
Selling Gen & administrative expense11 M35 M65 M81 M105 M65 M
SellingAndMarketingExpense11 M-100000.0-262000.081 M105 M65 M
SellingExpense11 M81 M105 M65 M
Total Income available for interest expense (EBIT)-41 M-63 M-82 M-96 M-134 M-38 M
Total common shares outstanding491121.0677657.0736077.01 M73 M2 M
Total net income-42 M-67 M-90 M-104 M-143 M-45 M
Total ordinary shares3 M3 M3 M3 M3 M3 M
Total revenues0.05 M6 M8 M11 M4 M
TotalExpenses-40 M65 M90 M103 M-141 M-86 M
TotalRevenue9 M5 M6 M8 M11 M4 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today